中国肺癌杂志2019，Vol.22Issue(9)：562-567,6.DOI:10.3779/j.issn.1009-3419.2019.09.02
Comparison of Effectiveness of Gefitinib, Erlotinib, and Afatinib in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutation Positive in Indonesian Population
Comparison of Effectiveness of Gefitinib, Erlotinib, and Afatinib in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutation Positive in Indonesian Population
Noorwati SUTANDYO 1Arif HANAFI 2Mulawarman JAYUSMAN2
作者信息
- 1. Division of Hematology and Medical Oncology,Department of Internal Medicine
- 2. Department of Pulmonology,Dharmais National Cancer Centre Hospital,Jakarta,Indonesia
- 折叠
摘要
关键词
Lung neoplasms/EGFR mutation positive/Tyrosine kinase inhibitorsKey words
Lung neoplasms/EGFR mutation positive/Tyrosine kinase inhibitors引用本文复制引用
Noorwati SUTANDYO,Arif HANAFI,Mulawarman JAYUSMAN..Comparison of Effectiveness of Gefitinib, Erlotinib, and Afatinib in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutation Positive in Indonesian Population[J].中国肺癌杂志,2019,22(9):562-567,6.
